Sign in

CIK 0001727196

  • Non-accelerated filer

Scholar Rock Holding Corp

Sign in to watch
Ticker
SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823750435
Phone
+1 857-259-3860
Business address
301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$11,999,922
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. AKKARAJU SRINIVAS +$12.0M Director 1 filing

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-09-16 AKKARAJU SRINIVAS Director Grant or award · Stock Option (Right to Buy) +56,000 56,000
2022-08-16 Parlavecchio Caryn CHRO Shares withheld for taxes −1,401 $11.34 $16K 78,649
2022-07-08 Gilman Michael Director Gift −37,459 0
2022-07-08 Gilman Michael Director Gift +37,459 37,459
2022-06-22 Nashat Amir Director Purchase +1,131,850 $4.90 $5.5M 3,540,530
2022-06-22 Nashat Amir Director Purchase +66,142 $4.90 $324K 206,897
2022-06-22 Nashat Amir Director Purchase · Common Warrant (right to buy) +282,962 $4.90 $1.4M 282,962
2022-06-22 Nashat Amir Director Purchase · Common Warrant (right to buy) +16,536 $4.90 $81K 16,536
2022-06-16 Vaishnaw Akshay Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2022-06-16 Parlavecchio Caryn CHRO Grant or award +35,750 80,050
2022-06-16 Parlavecchio Caryn CHRO Grant or award · Stock Option (Right to Buy) +35,750 35,750
2022-06-16 Myles Edward H COO & CFO Grant or award +74,750 154,222
2022-06-16 Myles Edward H COO & CFO Grant or award · Stock Option (Right to Buy) +74,750 74,750
2022-06-16 Mahanthappa Nagesh K. Interim CEO and President Grant or award +50,000 480,491
2022-06-16 Mahanthappa Nagesh K. Interim CEO and President Grant or award · Stock Option (Right to Buy) +50,000 50,000
2022-06-16 Ho Junlin General Counsel Grant or award +45,500 120,591
2022-06-16 Ho Junlin General Counsel Grant or award · Stock Option (Right to Buy) +45,500 45,500
2022-06-16 Hallal David Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2022-06-16 Gilman Michael Director Grant or award · Stock Option (Right to Buy) +14,000 14,000
2022-06-16 Carven Gregory John Chief Scientific Officer Grant or award +45,500 128,208

Page 21 of 22 · 422 trades